Once-Daily OROS ® Methylphenidate Is Safe and Well Tolerated in Adolescents With Attention-Deficit/Hyperactivity Disorder
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
This 8-week, open-label extension of a double-blind study reports on safety data for 171 adolescents with attention-deficit/hyperactivity disorder (ADHD) who received once-daily OROS methylphenidate (MPH) (18-72 mg/day). Headache, anorexia, and insomnia were the most frequently reported treatment-related adverse events. The incidence of adverse events was not related to dose. OROS MPH was safe and well tolerated at doses up to 72 mg/day.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498 · cited 1×
“For these patients hyperactivity and impulsivity (Biederman et al. 2000).”
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Self-citationPharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Self-citationHart, E. L., Lahey, B. B., Loeber, R., Applegate, B., & Frick, P. J. (1995) · Journal of Abnormal Child Psychology · doi:10.1007/bf01447474 · Cited by 590
Wolraich, M. L., Greenhill, L. L., Pelham, W., Swanson, J., Wilens, T., Palumbo, D., Atkins, M., McBurnett, K., Bukstein, O., August, G., et al. (2001) · Pediatrics · doi:10.1542/peds.108.4.883 · Cited by 502
Self-citationPelham, W. E., Gnagy, E. M., Burrows-Maclean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., Chronis, A. M., Forehand, G. L., Nguyen, C. A., Hoffman, M. T., et al. (2001) · Pediatrics · doi:10.1542/peds.107.6.e105 · Cited by 378
GREENHILL, L. L., SWANSON, J. M., VITIELLO, B., DAVIES, M., CLEVENGER, W., WU, M., ARNOLD, L. E., ABIKOFF, H. B., BUKSTEIN, O. G., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00012 · Cited by 287
Self-citationGREENHILL, L. L., HALPERIN, J. M., & ABIKOFF, H. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00011 · Cited by 268
Self-citationAttention-deficit/hyperactivity disorder: increased costs for patients and their families
SWENSEN, A. R., BIRNBAUM, H. G., SECNIK, K., MARYNCHENKO, M., GREENBERG, P., & CLAXTON, A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200312000-00008 · Cited by 189 · cited 1×
“…(Barkley et al. 1990a; Mannuzza et al. 1997; Murphy et al. 2002), poorer employment outcomes (Mannuzza et al. 1997), and increased rates of alcohol and illicit drug abuse (Barkley et al. 1990a; Murphy et al. 2002) while also incurring higher health care costs (Barkley 2002; Swensen et al. 2003).”
Cited by
Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours
Makale, M. T., McDonald, C. R., Hattangadi-Gluth, J. A., & Kesari, S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.185 · Cited by 527
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Storebø, O. J., Pedersen, N., Ramstad, E., Kielsholm, M. L., Nielsen, S. S., Krogh, H. B., Moreira-Maia, C. R., Magnusson, F. L., Holmskov, M., Gerner, T., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012069.pub2 · Cited by 321
Stiefel, G., & Besag, F. M. C. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 257
Ching, C., Eslick, G. D., & Poulton, A. S. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.0905 · Cited by 70
Hammerness, P., Wilens, T., Mick, E., Spencer, T., Doyle, R., McCreary, M., Becker, J., & Biederman, J. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.02.008 · Cited by 57
Self-citationRamos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54
Cocaine responsiveness or anhedonia in rats treated with methylphenidate during adolescence
Ferguson, S. A., & Boctor, S. Y. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.03.007 · Cited by 23
Metadata
- Authors
- McGough, J. J., McBurnett, K., Bukstein, O., Wilens, T. E., Greenhill, L., Lerner, M., & Stein, M.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-06
- Volume
- 16
- Issue
- 3
- Pages
- 351-356
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2036013796
- Cited by
- 37
- References
- 11
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.